| 2023-03-24 |
Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system |
Virus Research. 2023 Mar 24;329:Article number 199101. |
 |
| 2022-09-15 |
The uncoating of EV71 in mature late endosomes requires CD-M6PR |
Biology Open. 2022 Sep 15;11(9):Article number bio059469. |
|
| 2018-05 |
Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture |
Vaccine. 2018 May;36(22):3134-3139. |
|
| 2018-04-18 |
Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery |
ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561. |
|
| 2016-11-09 |
Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy |
Scientific Reports. 2016 Nov 09;6:Article number 36732. |
|
| 2016-11 |
Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus |
Microbes and Infection. 2016 Nov;18(11):706-709. |
|
| 2016-08 |
Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology |
Antiviral Research. 2016 Aug;132:225-232. |
|
| 2016-07-29 |
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice |
Scientific Reports. 2016 Jul 29;6:Article number 30648. |
|
| 2016-07 |
The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection |
Human Vaccines and Immunotherapeutics. 2016 Jul;12(7):1678-1689. |
|
| 2016-05 |
Immunological and biochemical characterizations of Coxsackievirus A6 and A10 viral particles |
Antiviral Research. 2016 May;129:58-66. |
|
| 2016-02 |
Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice |
Vaccine. 2016 Feb;34(8):1054-1061. |
|
| 2015-12-29 |
The immunodominance change and protection of CD4+ T-cell responses elicited by an envelope protein domain III-based tetravalent dengue vaccine in mice |
PLoS ONE. 2015 Dec 29;10(12):Article number e0145717. |
|
| 2015-12 |
Recombinant bacterial lipoproteins as vaccine candidates |
Expert Review of Vaccines. 2015 Dec;14(12):1623-1632. |
|
| 2015-12 |
Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection |
International Journal of Infectious Diseases. 2015 Dec;41:56-64. |
|
| 2015-11 |
Is a multivalent hand, foot, and mouth disease vaccine feasible? |
Human Vaccines and Immunotherapeutics. 2015 Nov;11(11):2688-2704. |
|
| 2015-08-13 |
Biochemical and immunological characterization of truncated fragments of the receptor-binding domains of C. difficile toxin A |
PLoS ONE. 2015 Aug 13;10(8):Article number e0135045. |
|
| 2015-08-07 |
Recombinant lipoprotein-based vaccine candidates against C. difficile infections |
Journal of Biomedical Science. 2015 Aug 7;22:Article number 65. |
|
| 2015-06 |
Recombinant lipoproteins as novel vaccines with intrinsic adjuvant |
Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74. |
|
| 2015-04 |
Recombinant adeno-vaccine expressing Enterovirus 71-like particles against hand, foot, and mouth disease |
PLoS Neglected Tropical Diseases. 2015 Apr;9(4):Article number e0003692. |
|
| 2015-03 |
Review of enterovirus 71 vaccines |
Clinical Infectious Diseases. 2015 Mar;60(5):797-803. |
|
|
Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology |
Human Vaccines and Immunotherapeutics. 2015 Apr;11(4):1065-1073. |
|
| 2014-11 |
Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide |
Human Vaccines and Immunotherapeutics. 2014 Nov;10(11):3241-3250. |
|
| 2014-10 |
Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases |
Vaccine. 2014 Oct;32(47):6177-6182. |
|
| 2014-09-08 |
Long-term immunogenicity studies of formalin-inactivated Enterovirus 71 whole-virion vaccine in macaques |
PLoS ONE. 2014 Sep 8;9(9):Article number e106756. |
|
| 2014-09 |
A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus |
Journal of General Virology. 2014 Sep;95(Pt 9):1983-1990. |
|
| 2014-08-27 |
Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice |
BioMed Research International. 2014 Aug 27;2014:Article number 878139. |
|
| 2014-07-30 |
Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns |
Journal of Virology. 2014 Jul 30;88(20):11658-11670. |
|
| 2014-06-11 |
Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems |
Biomed Research International. 2014 Jun 11;2014:Article number 670506. |
|
| 2014-05 |
Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells |
Journal of Immunology. 2014 May;192(9):4233-4241. |
|
| 2014-03 |
Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity |
Vaccine. 2014 Mar;32(12):1346-1353. |
|
| 2014-03 |
A purified recombinant lipopeptide as adjuvant for cancer immunotherapy |
BioMed Research International. 2014 Mar;2014:Article number 349783. |
|
| 2014-01 |
A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity |
Journal of Controlled Release. 2014 Jan;173(1):158-165. |
|
| 2014-01 |
Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide |
Biomaterials. 2014 Jan;35(5):1686-1695. |
|
| 2013-12 |
The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: A Phase I trial in Taiwan |
Journal of Microbiology, Immunology and Infection. 2013 Dec;46(6):448-455. |
|
| 2013-11-21 |
Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers |
PLoS ONE. 2013 Nov 21;8(11):Article number e79783. |
|
| 2013-11 |
Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV |
Human Vaccines and Immunotherapeutics. 2013 Nov ;9(11):2378-2385. |
|
| 2013-09-19 |
Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement |
PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432. |
|
| 2013-09 |
Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III |
Microbes and Infection. 2013 Sep;15(10-11):719-728. |
|
| 2013-07-30 |
Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice |
PLoS ONE. 2013 Jul 30;8(7):Article number e69858. |
|
| 2013-07 |
A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates |
Archives of Virology. 2013 Jul;158(7):1523-1531. |
|
| 2013-06-13 |
Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence |
ACS Medicinal Chemistry Letters. 2013 Jun 13;4(6):522-526. |
|
| 2013-05 |
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine |
Vaccine. 2013 May;31(20):2471-2476. |
|
| 2013-05 |
Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines |
Journal of Immunology. 2013 May;190(10):5065-5077. |
|
| 2013-02-25 |
Human SCARB2 transgenic mice as an infectious animal model for Enterovirus 71 |
PLoS ONE. 2013 Feb 25;8(2):Article number e57591. |
|
| 2013-01 |
Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells |
Immunobiology. 2013 Jan;218(1):90-95. |
|
| 2012-12 |
Production of EV71 vaccine candidates |
Human Vaccine Immunotherapy. 2012 Dec;8(12):1775-1783. |
|
| 2012-11-30 |
Immunological and biochemical characterization of Coxsackie Virus A16 viral particles |
PLoS ONE. 2012 Nov 30;7(11):Article number e49973. |
|
| 2012-09 |
Immunological evaluation and comparison of different EV71 vaccine candidates |
Clinical and Developmental Immunology. 2012 Sep;2012:Article ID 831282. |
|
| 2012-08-28 |
Challenges to licensure of enterovirus 71 vaccines |
PLoS Neglected Tropical Diseases. 2012 Aug 28;6(8):Article number e1737. |
|
| 2012-08 |
CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17–Polarizing conditions |
Journal of Immunology. 2012 Aug;189(4):1671-1679. |
|
